Jim Cramer says he can’t sell Eli Lilly despite its massive run up. Here’s why
RSS SUMMARY · AGGREGATED FROM CNBC
"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.
"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.
"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Silicon Valley’s new buyout playbook is hitting Wall Street
CNBC·1h ago·3 min read
Business
Airlines find the grass isn’t always greener with new engines
CNBC·1h ago·3 min read
US
JPMorgan traders are getting worried and have turned cautious on the market. Here’s why
CNBC·3h ago·3 min read
US
Congress moves toward approving $70 billion for ICE and CBP through Trump’s presidency
CNBC·4h ago·3 min read
Related
On this beat
Health
Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects
TWSJ·7h ago·3 min read
Health
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC·9h ago·3 min read
Health
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
TWSJ·9h ago·3 min read
Health
Life After A Spinal Injury: A Guide to Physical And Mental Recovery
AOHL·11h ago·3 min read